Clinical Trial Update: Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Intravenous immunoglobulin for treating Primary Sjögren's syndrome-associated painful sensory neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Primary Sjögren's Syndrome Painful Sensory Neuropathies | Phase 3 | Status: COMPLETED